Katano, Yoshiaki

Publishing since 1992 (Senior)

Has published 78 publications in 19 years

Number of publications published per year by Katano, Yoshiaki. (Source : PubMed)

Distribution of publications types for Katano, Yoshiaki. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Hayashi K, Katano Y, Ishigami M, Itoh A, Hirooka Y, Nakano I, Yoshioka K, Yano M, Toyoda H, Kumada T, Goto H. Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains.  J. Gastroenterol. Hepatol.  2010  
•  Karino Y, Toyota J, Kumada H, Katano Y, Izumi N, Kobashi H, Sata M, Moriyama M, Imazeki F, Kage M, Ishikawa H, Masaki N, Seriu T, Omata M. Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.  Hepatology international  2010;4;1  
•  Tachi Y, Katano Y, Honda T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Samejima Y, Goto H. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.  Liver Int.  2009  
•  Hirooka Y, Itoh A, Kawashima H, Ohno E, Ishikawa T, Matsubara H, Itoh Y, Nakamura M, Miyahara R, Ohmiya N, Niwa Y, Ishigami M, Katano Y, Goto H. Diagnosis of pancreatic disorders using contrast-enhanced endoscopic ultrasonography and endoscopic elastography.  Clin. Gastroenterol. Hepatol.  2009;7;11 Suppl  
•  Kuzuya T, Takeda K, Utsunomiya S, Taga M, Kawata N, Ikeda T, Imai N, Mizutani Y, Hirose K, Ishikawa T, Katano Y, Goto H. [A case of hepatitis B-related multiple hepatocellular carcinomas, most of which lead to necrosis possibly due to the implantation of an arterial infusion catheter]  Gan To Kagaku Ryoho  2009;36;12  
•  Honda T, Katano Y, Shimizu J, Ishizu Y, Doizaki M, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C.  Liver Int.  2009  
•  Hayashi H, Fujita Y, Tatsumi Y, Hattori A, Hayashi K, Katano Y, Wakusawa S, Yano M, Itoh M, Mizutani N, Goto H. Special stain and X-ray probe microanalysis of livers with Wilson disease.  Hepatol. Res.  2009;39;6  
•  Hirooka Y, Itoh A, Kawashima H, Hara K, Nonogaki K, Kasugai T, Ohno E, Ishikawa T, Matsubara H, Ishigami M, Katano Y, Ohmiya N, Niwa Y, Yamamoto K, Kaneko T, Nieda M, Yokokawa K, Goto H. A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer.  Pancreas  2009;38;3  
•  Katano Y, Kumada T, Nakano I, Toyoda H, Ishigami M, Hayashi K, Honda T, Goto H. Comparison of biochemical safety between PEG-IFN alpha-2a and PEG-IFN alpha-2b.  Hepatogastroenterology  2009;56;90  
•  Hayashi K, Katano Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy.  J. Med. Virol.  2009;81;3  

[ See timeline ] [ See all publications ]